Back to Search
TYLER ANDEREGG, M.D.
M.D.
Anesthesiology Physician
NPI: 1619219391IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
82487(GA)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OTHER
Class of 2013
Research & Publications (18)
Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
PMID 15967640·Int J Antimicrob Agents·2005
8-other
Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
PMID 15878443·Diagn Microbiol Infect Dis·2005
8-other
Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
PMID 15695708·J Clin Microbiol·2005
8-other
Bactericidal activity of garenoxacin tested by kill-curve methodology against wild type and QRDR mutant strains of Streptococcus pneumoniae.
PMID 15541608·Diagn Microbiol Infect Dis·2004
8-other
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used.
PMID 15243116·J Clin Microbiol·2004
8-other
Quality control guidelines for MIC susceptibility testing of omiganan pentahydrochloride (MBI 226), a novel antimicrobial peptide.
PMID 15004130·J Clin Microbiol·2004
8-other
Disk diffusion quality control guidelines for NVP-PDF 713: a novel peptide deformylase inhibitor.
PMID 14761722·Diagn Microbiol Infect Dis·2004
4-observational
Preliminary susceptibility testing guidelines for AZD2563, a long-acting oxazolidinone.
PMID 14732307·Int J Antimicrob Agents·2004
8-other
Validation of commercial dry-form broth microdilution panels for susceptibility testing of AZD2563, a new long-acting oxazolidinone.
PMID 12848732·Clin Microbiol Infect·2003
8-other
Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitor.
PMID 12842335·Int J Antimicrob Agents·2003
4-observational
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae.
PMID 12812719·Diagn Microbiol Infect Dis·2003
4-observational
Initial quality control evaluations for susceptibility testing of Dalbavancin (BI397), an investigational glycopeptide with potent gram-positive activity.
PMID 12791936·J Clin Microbiol·2003
8-other
Initial disk diffusion quality control guidelines for tylosin tested against Staphylococcus aureus ATCC 25923 and Streptococcus pneumoniae ATCC 49619.
PMID 12791478·Int J Antimicrob Agents·2003
8-other
Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.
PMID 12573554·Diagn Microbiol Infect Dis·2003
8-other
In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
PMID 12121951·Antimicrob Agents Chemother·2002
4-observational
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains.
PMID 12052634·Diagn Microbiol Infect Dis·2002
8-other
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
PMID 12039896·J Antimicrob Chemother·2002
4-observational
In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species.
PMID 11858907·Diagn Microbiol Infect Dis·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 300 W HOSPITAL RD
FORT EISENHOWER, GA 30905 - Phone
- (706) 787-4007
Quick Facts
- NPI
- 1619219391
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 13
- Publications
- 18
Are you this provider?
Claim Your Profile